Variant report
Variant | esv3429814 |
---|---|
Chromosome Location | chr20:12959638-12960204 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:12959607..12961682-chr20:14555879..14557670,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574929633 | chr20:12959669-12959670 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537649403 | chr20:12959679-12959680 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138131754 | chr20:12959694-12959695 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs6041746 | chr20:12959724-12959725 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs556268245 | chr20:12959777-12959778 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6074534 | chr20:12959781-12959782 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369743011 | chr20:12959802-12959803 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573180540 | chr20:12959836-12959837 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149555075 | chr20:12959855-12959856 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527984001 | chr20:12959869-12959870 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562053959 | chr20:12959870-12959871 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540187172 | chr20:12959884-12959885 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1321940 | chr20:12959885-12959886 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs550409147 | chr20:12959918-12959919 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs118134534 | chr20:12959948-12959949 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6074535 | chr20:12959966-12959967 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6105009 | chr20:12959979-12959980 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs570727469 | chr20:12960002-12960003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187769898 | chr20:12960007-12960008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139405393 | chr20:12960021-12960022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs147249005 | chr20:12960089-12960090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572660647 | chr20:12960124-12960125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549022385 | chr20:12960139-12960140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540027491 | chr20:12960144-12960145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs6078854 | chr20:12960153-12960154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs556253552 | chr20:12960193-12960194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112265788 | chr20:12960198-12960199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569546303 | chr20:12960204-12960205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 16397240 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Glaucoma | 21310917 | CNVD |
Alagille syndrome | 22470819 | CNVD |
Lung cancer | 16773561 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Kabuki syndrome | 21720541 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22102821 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:12951600-12964600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr20:12957200-12960000 | Enhancers | Fetal Intestine Large | intestine |
3 | chr20:12958200-12964600 | Weak transcription | Stomach Mucosa | stomach |
4 | chr20:12958400-12960000 | Enhancers | Liver | Liver |
5 | chr20:12958600-12960000 | Flanking Active TSS | HepG2 | liver |
6 | chr20:12959000-12964800 | Weak transcription | Placenta | Placenta |
7 | chr20:12959600-12959800 | Enhancers | A549 | lung |
8 | chr20:12959800-12960000 | Weak transcription | A549 | lung |
9 | chr20:12960000-12961600 | Enhancers | HepG2 | liver |